Goodwin
Tevia Pollard
- Deals
- 4
- Latest
- Aug 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 4 deals
Often works with
- Bill Collins 2 deals together
- Gabriela Morales-Rivera 2 deals together
- Andrea Akinbola 2 deals together
- Timbre Griffin 2 deals together
- Keerthi Adusumilli 2 deals together
- Madeleine Popp 2 deals together
- Claire Treesh 2 deals together
- Haylee Brown 2 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Aug 2026 | Slate Medicines | – | Fulcrum Therapeutics | Merger | Legal adviser to Fulcrum Therapeutics | Announced | – | Biotech+1 | Fulcrum Therapeutics and Slate Medicines merger |
| Apr 2026 | Robocath | – | Stereotaxis | Acquisition | Legal adviser to Robocath (target) | Announced | – | Medtech+1 | Stereotaxis acquisition of Robocath |
| Apr 2026 | Obsidian Therapeutics | – | – | Placement | Legal adviser to Obsidian Therapeutics | Completed | 350.0 | Biotech+2 | Obsidian Therapeutics placement |
| Apr 2026 | Obsidian Therapeutics | – | Galera Therapeutics | Merger | Legal adviser to Obsidian Therapeutics | Completed | 413.5 | Biotech+2 | Galera Therapeutics and Obsidian Therapeutics merger |
Deals where Tevia Pollard is named on the firm's deal team, by the firm or the press.